Plaintiff
Defendant
- Parties: The plaintiffs were Boehringer Ingelheim (Canada) Ltd and Boehringer Ingelheim International GMBH. The defendant was Auro Pharma Inc.
- Subject Matter: This action involved the Patented Medicines (NOC) Regulations.
- Date: The hearing was set on Jan. 19, 2024.
- Venue: This was a federal case before the Federal Court.
- Amount: No financial award was specified.
Court
Federal CourtCase Number
T-1336-23Practice Area
Intellectual propertyAmount
Winner
Trial Start Date
29 June 2023Download documents